Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02306473 · ClinicalTrials.gov registry record · Early Phase 1
The Leaky Lung Test
A Early Phase 1 study of Asthma and Allergy, sponsored by University of Rochester.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02306473: Completed Early Phase 1 study of Asthma and Allergy, sponsored by University of Rochester.
NCT02306473 is a Early Phase 1 study of Asthma and Allergy that has completed, run by University of Rochester. The registered enrollment target is 100 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02306473, a Early Phase 1 study of Asthma and Allergy, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a clinical trial designed to test the hypothesis that measuring the absorption and excretion of inhaled mannitol will provide a clinically useful marker of airway epithelial permeability in asthma.
Primary Outcome
Urinary clearance of mannitol overtime
Conditions Studied
Interventions
- DRUG Mannitol
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-12-01 |
| Phase | Early Phase 1 |
What the finished NCT02306473 record still lists
NCT02306473 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (94% lower).
The record links to 4 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Mannitol is the first listed.
NCT02306473 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02306473 about?
NCT02306473 is a clinical study titled "The Leaky Lung Test". This is a clinical trial designed to test the hypothesis that measuring the absorption and excretion of inhaled mannitol will provide a clinically useful marker of airway epithelial permeability in asthma.
What is the current status of trial NCT02306473?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 100 participants. The study started on 2015-10. Estimated completion is 2017-12-01.
What conditions does trial NCT02306473 study?
This clinical trial studies the following conditions: Asthma, Allergy, Lung Diseases, Obstructive, Reactive Airway Disease.
What interventions are being tested in trial NCT02306473?
The interventions under investigation include: Mannitol (DRUG).
Who is sponsoring clinical trial NCT02306473?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02306473 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02306473's enrollment target sits among peer trials
100 211th of 374 higher than 160 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Vaginal Microbiome Exposure and Immune Responses in C-section Infants
ACTIVE NOT RECRUITING · Early Phase 1
-
Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions
COMPLETED · Early Phase 1
-
Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions
COMPLETED · Early Phase 1
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia